The CTO study shows that a majority of scientists working in clinical trials (77%) are generally satisfied with the overall process, although many bring up important issues that affect the clinical trial process — and possibly the results.
To collect opinions for the Clinical Trial Overview survey, The Science Advisory Board invited scientists who have published work on ClinicalTrials.gov to complete an online questionnaire. This research yielded over 1,000 responses during the first quarter of 2016. The survey does not include the opinion of scientists who have not been published on ClinicalTrials.gov . Opinions expressed in the CTO study, or reported within this release, were those solely of the participants. The Science Advisory Board, or its sponsor, BioInformatics, LLC, do not endorse or refute the findings from the CTO. For additional information regarding this study, contact Quentin Kreilmann (email@example.com) or Sunny Piya (firstname.lastname@example.org).
About The Science Advisory Board:
The Science Advisory Board (http://www.scienceboard.net) is an international community of scientific and medical experts. Its mission is to be the catalyst for future scientific and medical breakthroughs. Members of this global network of research, development, and manufacturing professionals showcase their knowledge, share their experiences, and consult for leading life science and analytical companies — thereby shaping the future of scientific technology. The Science Advisory Board is sponsored by BioInformatics, LLC. Twitter: @Scienceboard